Press Releases - WDM Group PR Network
OncoSec Medical to Present at 3rd Annual Cancer Immunotherapy Conference
Tasquinimod Biomarker Phase II data presented at ESMO 2012
Sunshine Heart Announces Conditional Approval of IDE From the FDA for C-Pulse(R) Heart Assist System
For further information, please contact:
Media:
Laura Landry
Blueprint Life Science Group
T: +1-415-375-3340
Investor:
Jeff Mathiesen
Chief Financial Officer
Sunshine Heart, Inc.
T: +1-952-345-4200
Audeo Oncology Announces New Board Appointments
For further information:
Dr. Pete Smith
Chief Executive Officer
Charles Walker
Chief Financial Officer
Audeo Oncology, Inc.
Tel: +61 7 3340 0200
MethylGene Presents Clinical Data on MGCD265 at the European Society for Medical Oncology (ESMO) 2012 Congress
Vice President, Business & Corporate Development
MethylGene Inc.
514-337-3333 ext. 373
ir@methylgene.com
www.methylgene.com
or
Thomas Hoffmann
Vice President
The Trout Group LLC
646-378-2931
thoffmann@troutgroup.com
www.troutgroup.com
Harte-Hanks Launches New Health & Wellness Brand Agency for the Healthcare Market: TRUE Health + Wellness(TM)
Media Contact:
TRUE Health + Wellness
Morayea Pindziak
(215) 944-9692
Email Contact
Novo Nordisk A/S - Share repurchase programme
Prana Announces A$6.0 Million Capital Raising
Contacts:
Australia
Prana Biotechnology
+61 3 9349 4906
US
Leslie Wolf-Creutzfeldt
T: 646-284-9472
E: leslie.wolf-creutzfeldt@grayling.com


